88 related articles for article (PubMed ID: 21567106)
1. Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C.
Bougen NM; Yang T; Chen H; Lobie PE; Perry JK
Oncol Rep; 2011 Aug; 26(2):487-93. PubMed ID: 21567106
[TBL] [Abstract][Full Text] [Related]
2. Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells.
Bougen NM; Steiner M; Pertziger M; Banerjee A; Brunet-Dunand SE; Zhu T; Lobie PE; Perry JK
Endocr Relat Cancer; 2012 Oct; 19(5):625-44. PubMed ID: 22807498
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone.
Zhu T; Starling-Emerald B; Zhang X; Lee KO; Gluckman PD; Mertani HC; Lobie PE
Cancer Res; 2005 Jan; 65(1):317-24. PubMed ID: 15665309
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.
Mukhina S; Mertani HC; Guo K; Lee KO; Gluckman PD; Lobie PE
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15166-71. PubMed ID: 15353581
[TBL] [Abstract][Full Text] [Related]
5. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
[TBL] [Abstract][Full Text] [Related]
6. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
[TBL] [Abstract][Full Text] [Related]
7. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
[TBL] [Abstract][Full Text] [Related]
8. Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.
Pandey V; Perry JK; Mohankumar KM; Kong XJ; Liu SM; Wu ZS; Mitchell MD; Zhu T; Lobie PE
Endocrinology; 2008 Aug; 149(8):3909-19. PubMed ID: 18450952
[TBL] [Abstract][Full Text] [Related]
9. p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis.
Zhu Z; Mukhina S; Zhu T; Mertani HC; Lee KO; Lobie PE
Oncogene; 2005 May; 24(23):3774-85. PubMed ID: 15782123
[TBL] [Abstract][Full Text] [Related]
10. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.
Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
[TBL] [Abstract][Full Text] [Related]
12. Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival.
Mertani HC; Zhu T; Goh EL; Lee KO; Morel G; Lobie PE
J Biol Chem; 2001 Jun; 276(24):21464-75. PubMed ID: 11297545
[TBL] [Abstract][Full Text] [Related]
13. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone.
Kaulsay KK; Mertani HC; Törnell J; Morel G; Lee KO; Lobie PE
Exp Cell Res; 1999 Jul; 250(1):35-50. PubMed ID: 10388519
[TBL] [Abstract][Full Text] [Related]
14. Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent.
Kaulsay KK; Mertani HC; Lee KO; Lobie PE
Endocrinology; 2000 Apr; 141(4):1571-84. PubMed ID: 10746665
[TBL] [Abstract][Full Text] [Related]
15. Mode of the autocrine/paracrine mechanism of growth hormone action.
Liu N; Mertani HC; Norstedt G; Törnell J; Lobie PE
Exp Cell Res; 1997 Nov; 237(1):196-206. PubMed ID: 9417883
[TBL] [Abstract][Full Text] [Related]
16. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
17. Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells.
Chen YJ; Zhang X; Wu ZS; Wang JJ; Lau AY; Zhu T; Lobie PE
Cancer Lett; 2015 Sep; 365(2):182-9. PubMed ID: 26070963
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma.
Xu XQ; Emerald BS; Goh EL; Kannan N; Miller LD; Gluckman PD; Liu ET; Lobie PE
J Biol Chem; 2005 Jun; 280(25):23987-4003. PubMed ID: 15845533
[TBL] [Abstract][Full Text] [Related]
19. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
Li PX; Ngo D; Brade AM; Klamut HJ
Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
[TBL] [Abstract][Full Text] [Related]
20. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
